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Technology
Identifying promising compounds from a vast collection of feasi-
ble compounds is an important and yet challenging problem in the
pharmaceutical industry. An efficient solution to this problem will
help reduce the expenditure at the early stages of drug discovery. In
an attempt to solve this problem, Mandal, Wu and Johnson [Techno-
metrics 48 (2006) 273–283] proposed the SELC algorithm. Although
powerful, it fails to extract substantial information from the data to
guide the search efficiently, as this methodology is not based on any
statistical modeling. The proposed approach uses Gaussian Process
(GP) modeling to improve upon SELC, and hence named G-SELC.
The performance of the proposed methodology is illustrated using
four and five dimensional test functions. Finally, we implement the
new algorithm on a real pharmaceutical data set for finding a group
of chemical compounds with optimal properties.
1. Introduction. Finding global optima of complex physical processes
with large input spaces (or search spaces) is one of the primary goals in
many scientific investigations. For example, scientists in pharmaceutical in-
dustries can often produce a large number of compounds. However, only
a few of them would serve as good candidates for a potential drug. While
compounds may be designed to be theoretically effective, their interactions
with different parts of the body (e.g., liver, kidney, intestine, etc.) often
render them ineffective or toxic [Welling (1997)]. Recent technological ad-
vancement has now enabled chemists to explore a large number of new po-
tential compounds in a short period of time. The technology, known as
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combinatorial chemistry, is now being widely applied in the pharmaceuti-
cal industry, and is gaining interest in several areas of chemical industry
as well [Lam, Welch and Young (2002), Leach and Gillet (2003), Gasteiger
and Engel (2003)]. Combinatorial chemistry uses robotics to combine sets
of monomers to create thousands of new compounds at a time. In a typical
compound, a core molecule is identified to which monomers are attached at
multiple locations. Each attachment location may have tens or hundreds of
potential monomers. Clearly, the compound library (set of all structurally
feasible compounds) can become dauntingly large for a core molecule with
just a few attachment points. This technology has been used in pharma-
ceutical industries to enhance the diversity of compound libraries, and to
optimize endpoints such as target efficacy or one (or more) of the ADMET
(absorption, distribution, metabolism, excretion, toxicology) properties of
compounds [Rouhi (2003)]. Constrained by resources, most compound li-
braries cannot be fully synthesized and, thus, it is preferred to find smaller
subsets of the libraries that consist of compounds with good desirable fea-
tures.
In practice, pharmaceutical industries frequently use ad hoc methods
based on the scientists’ prior knowledge and intuition to find subsets of
compound libraries that are small in size and contain compounds with de-
sirable properties. In Section 2 such an instance, which motivated the current
work, is discussed in more details. In this application the scientists used a
four-stage procedure to create a subset of compounds with high process
values (the exact chemical property of the response was not reported due
to propriety reasons). Recently, Mandal et al. (2006) developed a Genetic
Algorithm (GA)-based search procedure called Sequential Elimination of
Level Combinations (SELC) for this purpose, which was motivated by the
SEL algorithm of Wu, Mao and Ma (1990). SELC uses forbidden array and
weighted mutation to enhance the performance of the search procedure com-
pared to a standard GA [Holland (1975, 1992)]. Mandal et al. (2006) used
several examples and real applications to illustrate that SELC outperforms
classical GAs. Nonetheless, the lack of substantial statistical modeling in
SELC leaves room for improvement.
In this paper we propose using the Gaussian Process (GP) modeling tech-
nique [see Sacks et al. (1989)] for developing a sequential search method (G-
SELC). As illustrated in Sections 5 and 6, the new approach outperforms
SELC for the motivating pharmaceutical application and the simulated ex-
amples considered in the paper. G-SELC is inspired by the works of Jones,
Schonlau and Welch (1998), and Mandal et al. (2006). In their pioneering
work, Jones et al. (1998) proposed a complete sequential (one trial at a
time) sampling approach for process optimization by maximizing a merit
based criterion called an expected improvement (EI) function. It turns out
that restrictions on the compounds manufacturing process often requires
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chemical compounds to be manufactured in batches. That is, complete se-
quential approaches are undesirable for creating new promising compounds.
Thus, we propose to select batches of trials using an adaptive mixture of
SELC and EI. Four and five dimensional test functions are considered to
illustrate the performance of the proposed approach versus the existing ap-
proaches.
The paper is organized as follows. The motivating combinatorial chem-
istry problem of a pharmaceutical company is presented in Section 2. Then,
a brief review of the two existing methodologies, SELC and EI, are pre-
sented in Section 3. In Section 4 we develop the G-SELC technique. Section
5 presents a comparison on the performance of the new methodology with
that of the SELC and EI-based approach. In Section 6 G-SELC is used
for identifying potentially good compounds in the pharmaceutical industry
example. Some concluding remarks are given in Section 7.
2. Pharmaceutical chemistry example. Identifying promising compounds
from a vast collection of feasible compounds is a challenging problem in drug
discovery [see “Finding Needles” in Drug Discovery News, Willis (2007)].
This research is motivated by a combinatorial chemistry problem, where the
goal is to obtain sets of reagents (or monomers) that maximize the target ef-
ficacy of a compound, which is measured by its pre-specified physiochemical
property for a specific biological screen.
Consider the data discussed by Mandal et al. (2007), where a compound
was created by attaching reagents to the three locations denoted by A, B
and C (core) of a molecule (see Figure 1). The data were obtained from a
pharmaceutical company. In this application the compound library (the set
of all feasible compounds) consisted of 5 feasible substructures (monomers)
at position A, 34 at position B and 241 substructures at position C. That
is, the compound library had a total of 40,970 chemical compounds. Manu-
facturing all of these compounds was expensive, and thus, it was desirable
to select a much smaller subset of the compounds with desirable properties.
Once such a list of promising compounds was identified, the pharmacists
synthesized them in the laboratory, and then the compounds with high re-
sponses were chosen for further analysis.
Fig. 1. The core molecule of a compound with three reagents locations.
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Table 1
Characteristics of the subsets of the compound library chosen in different iterations of the
optimization procedure: each column represents the substructures explored in each
iteration and each row gives the number of new structures that were not examined in
previous rounds
Iteration A B C A×B A× C B × C A×B × C
1 5 26 164 75 286 1168 2114
2 0 7 9 17 18 102 208
3 0 1 41 1 41 120 128
4 0 0 27 0 27 32 33
Overall 5 34 241 93 372 1422 2483
To explore the compound space, the scientists of the pharmaceutical com-
pany performed a 4-stage experiment. An initial subset of 2114 compounds
was chosen on the basis of their scientific knowledge and intuition. These
compounds were then created and screened (i.e., the response y was ob-
tained). Using the results from this initial screen and scientific knowledge
about the target, three subsequent subsets of the compound library were
generated. In total, 2483 compounds (6% of the possible compounds) were
generated. Table 1 summarizes the substructure space explored at each itera-
tion, and provides insight into the historical process optimization technique.
In the first iteration 2114 compounds were created. Looking at the struc-
tures of those compounds, one would observe that in the first iteration all
the 5 substructures were explored for position A, 26 out of 34 substructures
for position B, and 164 out of 241 substructures were explored for position
C. Out of all possible 170 (=5×34) combinations of A×B, only 75 distinct
combinations occurred in the compounds of iteration 1. Other columns of
Table 1 can be interpreted similarly. Note that the column corresponding to
A×B×C represents the actual number of compounds created in a particu-
lar iteration. In the second iteration no new substructures were explored for
Table 2
Desired compound characteristics for combinatorial chemistry example
Reactive matched ¡1
Risky matched ¡3
Molecular weight ¡500
Rotatable bonds ¡10
Rule of 5 ¡2
Aromatic ring count ¡5
Polar surface area ¡140
logP ¡5
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position A (all were explored in the first iteration), but 7 new substructures
for position B and 9 new substructures for position C were explored.
Compounds with process value greater than 10 (i.e., y > 10) were con-
sidered active (or good). Although not modeled in this paper, the active
compounds that satisfy the constraints outlined in Table 2 were of more
importance to the scientists. These constraints include the chemical prop-
erties: chemical reactivity, occurrence of toxicologically risky chemical fea-
tures, molecular weight, number of rotatable bonds, violations of the Rule
of 5 [Lipinski et al. (1997)], aromatic rings, calculated polar surface area
and LogP (hydrophobicity). Of the 2483 compounds that were created, only
69% of the compounds satisfied the constraints in Table 2. The rest of the
compounds had one or more undesirable characteristics. As a result, the
number of active compounds found in the subset of size 2483 that met all
desired characteristics was low.
From an experimenter’s viewpoint, each compound can be thought of as
a design point (run) and the different reagents as levels of the factors (i.e.,
positions). The physiochemical property of interest (e.g., percent inhibition
values or any of the ADMET properties) of a compound can be viewed as
the univariate response of the process, which is to be maximized. That is, the
ith input (with d independent factors) and the output of the underlying pro-
cess evaluated at n design points can be denoted by a d-dimensional vector,
xi = (xi1, . . . , xid), and a scalar, yi = y(xi), respectively. Although we con-
sider only scalar valued response variables in this paper, multi-dimensional
response (e.g., optimization of more than one ADMET properties) can also
be accommodated by modeling the desirability scores [Mandal et al., (2007)]
of the compounds.
In such experiments, one or more factors are often qualitative by na-
ture, although in this paper we treat them as quantitative ones. Since the
monomers (or reagents) can be ranked based on their intrinsic properties
(viz. molecular weight, hydrophobicity or even abundance), such a simpli-
fication is justified in this setup. Hence, the proposed algorithm, G-SELC,
treats all the factors as quantitative (see Section 7 for more discussions).
Next, we review the two key components of the G-SELC algorithm.
3. Review of existing methodologies. The SELC algorithm developed in
Mandal et al. (2006) is a GA-based optimizer that attempts to find subsets
of the compound library which consist of good compounds. The EI approach
proposed in Jones et al. (1998) is a complete sequential design strategy that
is based on maximizing a figure of merit called the expected improvement
(EI).
3.1. SELC algorithm. The SELC algorithm was proposed as an exten-
sion of SEL [Wu et al. (1990)] for finding optima of sufficiently undulating
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Table 3
The factor settings of the nine compounds with their process value
A B C y
1 1 1 10.1
1 2 2 53.6
1 3 3 43.8
2 1 2 13.4
2 2 3 46.9
2 3 1 55.1
3 1 3 5.7
3 2 1 43.6
3 3 2 47.0
objective functions in a high-dimensional search space. This methodology
was based on classical GAs, and did not use any model based information
to search for the compounds with high process value (e.g., percent inhibition
values, any of the ADMET properties or desirability scores). The features
of the SELC algorithm that allow the algorithm to find optima quickly are
the forbidden array and weighted mutation scheme.
Forbidden array. A collection of design points that have demonstrated
poor fitness values, or a priori known to produce undesirable responses, is
said to form a forbidden array. Such an array can be characterized by its
strength and order. A forbidden array of strength s consists of the worst s
runs of the experiment at each iteration of the algorithm. A forbidden array
is said to be of order k if any combination of k or more levels from any design
point in the forbidden array is prevented from being constructed in subse-
quent iterations of the algorithm. For instance, suppose three monomers (de-
noted by 1, 2 and 3) can be added to each of the three locations A, B and C of
a core molecule as shown in Figure 1. Further suppose that only 9 compounds
are created and analyzed (see Table 3). The fourth column, denoted by y,
represents the process values of the 9 synthesized compounds. The forbidden
array of strength 2 for this design consists of the 2 compounds that have
the lowest y values, namely, (3 1 3) and (1 1 1). That is, the following com-
pounds will be prohibited: {(1 1 ∗), (1 ∗ 1), (∗ 1 1), (3 1 ∗), (3 ∗ 3), (∗ 1 3)},
where ∗ can take any admissible value.
Weighted mutation. The second main feature that makes the SELC al-
gorithm unique is its weighted mutation scheme. After constructing the for-
bidden array, SELC searches for promising compounds using a GA. The
crossover is done in the usual way. While in the mutation step of the GA,
the information obtained from the collected data is used to guide the search
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algorithm to focus on factors, and levels of factors that improve the fitness
criterion for the search. In the weighted mutation scheme of the SELC al-
gorithm, significant main effects and pairwise interactions are identified. If
a factor, Fj , has a significant main effect and no significant pairwise inter-
actions, then the mutation probability (pjl) for each level, l, of the factor is
proportional to the average fitness of that level for the data collected thus
far in the experiment:
pjl ∝ y¯(Fj = l) for j = 1,2, . . . , J, and l= 1,2, . . . ,L.
If the two factors, Fj and Fk, have a significant interaction, and either of
the two factors is chosen, the mutation is weighted jointly with probability
pjlkm ∝ y¯(Fj = l, Fk =m) for j, k = 1,2, . . . , J, and l,m= 1,2, . . . ,L.
If the selected factor does not have a significant main effect or interaction,
then its value will be changed to any possible level with equal probability.
In the SELC algorithm, the concept of forbidden arrays and weighted
mutations are combined with standard genetic algorithms. The algorithm
starts by selecting an initial design based on an appropriate orthogonal ar-
ray. If there is prior knowledge about the design space or design points,
the compounds with low process values are included in the forbidden ar-
ray. The desired compounds in the initial design are then manufactured
and the forbidden array is updated. New offspring (compounds) are selected
using a genetic algorithm with weighted mutation probabilities. Similar to
many optimization algorithms, the stopping rule for the SELC algorithm is
also subjective and depends on the progression of the algorithm and exper-
imental constraints. Next, we illustrate the limitations of SELC in terms of
identifying good compounds.
4D example (four dimensional problem). Consider a pharmaceutical ex-
periment setup, similar to that in Section 2, where the core molecule has
four locations A, B, C and D, and ten monomers can be added to each
of the four locations. This corresponds to an experiment with four fac-
tors each at ten levels 1 ≤ x·j ≤ 10, j = 1, . . . ,4. Further suppose that the
response of interest y(xi) is a scalar valued physiochemical property of a
compound, where xi = (xi1, xi2, xi3, xi4). For illustration purposes, we gen-
erate the responses using the 4-dimensional Levy function (see Section 5
for details). Since the true process values are known for all the 104 pos-
sible compounds (the entire compound library), the performance of SELC
for finding the maximum process value can be evaluated via simulation. We
used 500 simulations on designs of run size 150 each. For each simulation,
a 40-run minimax design [Johnson et al. (1990); John et al. (1995)] was
randomly chosen for an initial design. We used SELC to obtain the rest
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of the 110 designs points in batches of size b = 6, with the exception of
the last batch of two trials only. On average, SELC successfully identifies
the true global maximum only 23.4% of the times. In many situations (in-
cluding the pharmaceutical chemistry example), interest lies in obtaining
a few good candidates instead of the “absolute best.” The success rate for
capturing the top five maxima (including the global maximum) is 83.0%.
As we shall see in Section 5, G-SELC demonstrates a much better perfor-
mance.
3.2. Expected improvement approach. In the innovative approach devel-
oped in Jones et al. (1998), a stochastic process (Gaussian spatial process)
is used to model the underlying process. They developed a sequential design
strategy based on a figure of merit called the expected improvement function
[first introduced in Mockus, Tiesis and Zilinskas (1978)]. This technique of-
ten requires the fewest function evaluations compared to several competing
methods. Next, we describe two major components of this procedure: (a) the
Gaussian process model used to get a surrogate of the underlying process
and (b) the expected improvement function.
Although the modeling in Jones et al. (1998) was developed for a contin-
uous hyper-rectangle, the same modeling approach can be applied for both
discretized and continuous convex design regions. The n× d experiment de-
sign matrix, X , is the matrix of input trials, where the ith input trial is a
d-dimensional vector xi = (xi1, . . . , xid). The outputs for the simulation trials
y = y(X) = (y1, y2, . . . , yn)
′ are modeled as
y(xi) = µ+ z(xi); i= 1, . . . , n,(1)
where µ is the overall mean, and z(xi) is a Gaussian spatial process with
E(z(xi)) = 0, Var(z(xi)) = σ
2
z , and cov(z(xi), z(xj)) = σ
2
zRij . Jones et al.
(1998) used power exponential correlation given by
Rij = corr(z(xi), z(xj))
(2)
=
d∏
k=1
exp{−θk(xik − xjk)
pk} for all i, j,
to model the correlation structure of the underlying process, where the ex-
ponent, pk, is the smoothness parameter in the direction of the kth fac-
tor, k = 1, . . . , d, and θ = (θ1, . . . , θd) is the vector of hyper-parameters. The
power exponential correlation structure, for different values of pk and θ,
generates a large class of correlation functions. Another commonly used cor-
relation structure known as the product Mate´rn correlation function [Stein
(1999); Santner, Williams and Notz (2003)] can be used instead. It turns out
that, for the application in Section 2 and the examples in Section 5, both
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the product Mate´rn correlation and the power exponential family behave
very similarly. To save space, here we use the power exponential correla-
tion function. Specifying pk = 2 in the power exponential correlation (also
known as the Gaussian correlation) is a reasonable simplifying assumption
for the applications in this paper. Furthermore, if one or more factors (or
input variables) are qualitative, which is not very rare for pharmaceutical
experiments, one can use the correlation function proposed by Qian, Wu
and Wu (2008) to model the correlation structure.
In general, y(X) has multivariate normal distribution, y(X)∼Nn(1nµ,Σ),
where Σ = σ2zR and R= [Rij ]. The Gaussian process model can be used to
estimate responses at any nonsampled point x∗. The best linear unbiased
predictor (BLUP) for y(x∗) is
yˆ(x∗) = µˆ+ r′R−1(y − 1nµˆ),(3)
[see Santner, Williams and Notz (2003) for details] with mean squared error
s2(x∗) = σ2z
(
1− r′R−1r+
(1− 1′
n
R−1r)2
1′
n
R−11n
)
,(4)
where r = (r1(x
∗), . . . , rn(x
∗))′, and ri(x
∗) = corr(z(x∗), z(xi)) is defined in
equation (2). In practice the parameters are replaced with the maximum
likelihood estimates. For details on parameter estimation, uncertainty in
prediction and other model properties, see Jones et al. (1998) and Ranjan,
Bingham and Michailidis (2008).
Jones et al. (1998) argue that finding a global optimum of a process y(x)
by simply using the optima of its BLUP is not a good idea, as it does not
acknowledge the model uncertainty. They propose using a figure of merit
called “expected improvement” (EI), which balances local and global search.
Let fmax be the current estimate of the global maximum. Then, as in Jones
et al. (1998), the improvement in the estimate of the process maximum, by
including the design point x in the current sample, can be written as
I(x) =max{y(x)− fmax,0}.(5)
In our context, the improvement in the estimate of the highest process value,
by manufacturing a new compound, can be obtained using equation (5).
Jones et al. (1998) argue that by taking the expectation of the improvement
function, uncertainty in the model is taken into account. This formulation
ensures the exploration of the design space both inside and outside the
neighborhood of the current maximum fmax. The corresponding expected
improvement at x ∈ χ (the design space) is given by
E[I(x)] = s2(x)φ
(
yˆ(x)− fmax
s(x)
)
(6)
+ (yˆ(x)− fmax)Φ
(
yˆ(x)− fmax
s(x)
)
,
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where φ(·) and Φ(·) are the standard normal probability density function
and cumulative distribution function respectively [see Jones et al. (1998)
and Ranjan et al. (2008) for details].
Since the proposed technique in Jones et al. (1998) is a complete sequential
strategy (one trial at a time), and developing an efficient EI-based batch
sequential design is in itself a challenging problem, we adapt the existing
procedure to select a batch of b trials. This is done by first choosing ⌈αb⌉
trials (0≤ α≤ 1) from the top, instead of the top most design point, in the
candidate set ranked according to their EI values. Here, ⌈w⌉ denotes the
smallest integer greater than or equal to w. Note that selecting more than
one trial from the top of the sorted EI vector will not be beneficial if the
EI function is either unimodal, or its highest peak is much higher than the
other peaks. In the illustrative examples and the real applications considered
in this paper, EI functions are often multimodal with comparable heights.
The following example illustrates the performance of this methodology for
the pharmaceutical scenario presented in Section 3.1.
4D example (contd.). Instead of using SELC, we use the adapted EI ap-
proach for choosing the additional 110 trials in batches of size 6 each. Similar
to the illustration of SELC, the average performance of this algorithm was
observed based on 500 simulations. The adapted EI algorithm successfully
identifies the true global maximum only 19.6% of the times, and the overall
success rate for capturing the top five maxima (including the global maxi-
mum) is 24.6%.
Clearly, the ability of this algorithm for capturing the global maxima,
along with some near-optima, is not outstanding. This is not surprising
because the improvement function defined in equation (5) is targeted for the
global maximum. Earlier we have seen that the performance of SELC alone
is not outstanding either. Now we propose a new approach that improves
upon the SELC algorithm using the EI-based sampling scheme. The SELC
part of it captures the good compounds that may not be the best one, and
the adapted EI part targets the best compound and minimizes the overall
model uncertainty.
4. G-SELC: New algorithm—GP based SELC. A new batch-sequential
methodology for constructing a subset of the compound library is now devel-
oped. In short, the new algorithm uses an adaptive mixture of the batches of
trials obtained from the two approaches, where the mixing ratio α depends
on the peakedness and modality of the current estimate of the predicted
surface. We call this new algorithm G-SELC.
Suppose the compound library consists of M compounds that can be
manufactured if required. Assuming that the process evaluation (i.e., cre-
ation of a new compound) is expensive, the budget on the number of com-
pounds N(≪M) to be created is often fixed. Further assume that it is
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preferred to manufacture compounds in batches of size b each. Consider-
ing these constraints, we construct a subset of the combinational library
by first selecting an initial design of size n = n0 to get an overall idea of
the underlying process. We use a minimax design [Johnson et al. (1990);
John et al. (1995)] to construct an initial design of size n0. Alternatively,
one can use other space-filling designs (e.g., orthogonal array based Latin
Hypercube designs [Tang (1993)] and uniform coverage designs [Lam et al.
(2002)]). The data obtained from the initial set of compounds is then used
to fit a Gaussian process model to estimate the underlying process. Next,
the peakedness and the modality of the surrogate is used to estimate the
mixing ratio α.
If b compounds are selected at each stage, ⌈αb⌉ of them are selected using
the adapted EI criterion and the remaining b− ⌈αb⌉ compounds by SELC.
Note that the EI-part of the G-SELC performs a directed search, whereas
the SELC-part does it randomly and explores the unexplored regions of
the design space more frequently. If the fitted response surface is relatively
simple and has only one peak, that is, there is only one cluster of good com-
pounds, then it is logical to choose one (or, very few) candidate(s) in the
region of best predicted value based on EI-part, and utilize the remaining
candidates to explore other regions using the SELC-part. Similarly, if there
are two distinguishable peaks of the predicted response surface (i.e., there
are two distinct clusters of points with high predicted value), then it is nat-
ural to select twice as many candidates compared to the previous case, and
to choose the remaining runs randomly (using SELC) from the unexplored
regions.
This motivates the formulation of the mixing ratio α. Although the appli-
cation at hand has discretized space, we develop the theory of mixing ratio
for a more general setup. Let χ be a convex search space. Define
S = {x ∈ χ : yˆ(x)> cfmax}(7)
to be the region that consists of design points with high process values,
where c < 1 and fmax > 0 is the current estimate of the process maximum.
Of course, the choice of c is subjective and can be based on prior information
about the underlying process. Let k be the number of distinguishable clusters
of points in S. Note that it is possible that the underlying process has more
than k distinct modes, and the undetected peaks are not high enough to
include design points with high process values. We use a k-means clustering
algorithm to identify the clusters and cross-validation techniques to minimize
the total probability of misclassification in order to find the right number of
clusters. If Ci’s are the clusters such that S =
⋃k
i=1Ci and Ci ∩ Cj = φ for
all i 6= j, then the mixing ratio α can be defined as
α=
k∑
i=1
Ar(Ci)
Ar(χ)
,
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Fig. 2. The fitted response function has two peaks—at height 0.3 there are two clear
clusters as demonstrated on the right most panel.
where Ar(R) is the area/volume of the region R. It is easy to verify that
0 < α < 1. If the design space is discrete (e.g., a fine grid, or a compound
library in our case), it is much easier to compute the value of α. Using Monte
Carlo approximation of the Ar(Ci)’s, one can simply estimate α by αˆ=
|S|
|χ| ,
where |R| is the cardinality of the set R. The batch of b new compounds to be
manufactured is a mixture of ⌈αb⌉ compounds from the EI-based sampling
scheme described above, and b − ⌈αb⌉ compounds are selected using the
SELC technique.
Let us illustrate this with a hypothetical example as depicted in Figure 2.
Let χ= [−2,2]2 be the design region. The left most panel illustrates that the
fitted surface has two distinct peaks of comparable heights, and the figures in
the other two panels show that the set S has k = 2 distinguishable clusters.
Under these settings, Ar(χ) = 4× 4 = 16 and Ar(C1) = Ar(C2) ≃ pi(
1
2
)2 =
0.785. Thus,
α=
0.785 + 0.785
16
=
1.57
16
= 0.098,
and ⌈αb⌉ = 2 if b = 16. That is, in a batch of 16 new compounds, 2 new
compounds will be found using the adapted EI method and the remaining
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14 compounds using the SELC algorithm. The batch-sequential sampling
mechanism using G-SELC is summarized as follows:
1. Choose an initial design of size n = n0, such that n0 is a small fraction
of the maximum allowable budget N . Usually, N is much smaller than
M , the total number of candidate design points (or the size of compound
library, in our context).
2. Fit a surrogate using Gaussian process model (1)–(4) on n data points.
Let yˆ(x), x ∈ χ be the predicted surface.
3. Construct the region S and the clusters Ci, i= 1, . . . , k. Then, evaluate
the mixing ratio α.
4. Choose ⌈αb⌉ best trials by sorting the set {E[I(xi)], i= 1, . . . ,M−n} and
b−⌈αb⌉ trials using the SELC algorithm to construct the batch of b new
compounds xnew = {xi,new, i= 1, . . . , b}.
5. Manufacture the compounds corresponding to the new trials xnew. Com-
pute the corresponding responses ynew = {y(xi,new), i= 1, . . . , b}.
6. Update the data x= [x′ :x′new]
′, y = [y′ :y′new]
′ and n= n+ b.
7. Repeat Step 2 to Step 6, until the budget allows or the optimum is
achieved with desired level of accuracy.
Note that the mixing ratio α changes from iteration to iteration and stabi-
lizes as the number of iterations increases. Next, we illustrate the findings
through some simulated examples and the pharmaceutical chemistry exam-
ple.
5. Simulated examples. To illustrate the relative performance of the pro-
posed approach compared to SELC and adapted EI, several examples are
now presented. We use random minimax designs (any good space filling de-
sign can be used instead) with n0 = 10 × d trials for initial designs. The
results reported in this section use the Gaussian correlation function for GP
modeling. The mixing ratio α is computed by taking c = 3/4 in equation
(7). Note that the choice of a batch size, b, may impact the performance of
the proposed approach. In each of the examples, several choices of b are con-
sidered and the performance is observed. In practice, the batch size may be
fixed beforehand because of the restrictions imposed by the experimenter.
We also present a few plots which aid in the evaluation of the approaches.
4D example (contd.). The performance of all the three search algorithms
is now assessed on their ability to find the global maximum and the other
top four maxima where the responses are generated using the 4-dimensional
Levy function [Levy and Montalvo (1985)]:
y(x1, . . . , xd) = sin
2
{
pi
(
x1 +2
4
)}
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Fig. 3. Performance of the three algorithms—percentage of success in identifying max-
ima: in each block, the left, middle and right columns represent EI, SELC and G-SELC
respectively.
+
d−1∑
i=1
(
xi − 2
4
)2{
1 + 10sin2
(
pi
(
xi +2
4
)
+ 1
)}
+
(
xd − 2
4
)2{
1 + sin2(2pi(xd − 1))
}
.
The Levy function is commonly used as a test function in the global opti-
mization literature [Boggs (1985)]. The performance of all the three algo-
rithms is averaged over 500 simulations with different run sizes and batch
sizes. The results are summarized in Table 4. The last two columns of Ta-
ble 4 contain the success rate of capturing the global maximum and the
overall performance in identifying the top 5 maxima (including the global
maximum).
It is clear from the last two columns of Table 4 that G-SELC outperforms
both SELC and the adapted version of EI. For example, when the total run
size is 150 and batch size 4, G-SELC finds the top five candidates 93.6% of
times, whereas SELC finds them 81.4% of the times and the success rate
for EI is less than 15%. The last column “Total” shows that the relative
performance of G-SELC over SELC and EI improves as the batch size b
decreases. As one might guess, the performance of all the three algorithms
increases with the increase in run size. Interestingly, the performance of
the adapted EI improves with the increase in batch size. This is somewhat
counterintuitive, as EI is expected to perform well for small batch sizes,
because in that case the surface estimate is updated more frequently.
Figure 3 depicts the success rates of the three algorithms for achieving
the maximum for different run sizes and batch sizes as shown in the “Max”
column of Table 4. The left most panel presents the results when the search
is stopped after 150 runs, the middle and the right most panel correspond
to run size 200 and 300, respectively. In each of the three panels, the three
blocks (from left to right) represent batch sizes 4, 6 and 10, respectively.
The left most column in each block (i.e., with a fixed run size and batch
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Table 4
Performance of the three different methods based on 500 simulations—percentage success
in identifying the top 5 maxima of the Le´vy function evaluated on a grid of 104 points
Batch
Run size size b Method 5th best 4th best 3rd best 2nd best Max Total
EI 0.0 0.0 0.0 0.4 14.0 14.4
4 SELC 14.6 1.4 33.0 10.8 21.6 81.4
G-SELC 4.2 0.2 21.8 7.8 59.6 93.6
EI 0.2 0.0 3.4 1.4 19.6 24.6
150 6 SELC 12.0 1.6 31.6 14.4 23.4 83.0
G-SELC 5.0 0.2 25.0 15.0 44.6 89.8
EI 0.4 0.0 10.0 0.8 30.2 41.4
10 SELC 11.6 1.0 33.6 14.0 21.4 81.6
G-SELC 5.2 1.2 30.2 15.8 39.2 91.6
EI 0.0 0.0 0.0 0.0 19.8 19.8
4 SELC 6.4 2.2 27.6 20.6 36.4 93.2
G-SELC 1.6 0.2 10.8 8.2 77.2 98.0
EI 0.0 0.0 0.0 0.2 24.6 24.8
200 6 SELC 8.0 2.0 27.4 20.2 32.8 90.4
G-SELC 1.6 0.2 18.4 13.4 63.2 96.8
EI 0.0 0.0 0.0 0.0 43.0 43.0
10 SELC 10.6 0.4 30.8 18.2 32.2 92.2
G-SELC 3.6 0.6 21.4 18.8 54.8 99.2
EI 2.5 0.0 3.5 1.0 31.5 38.5
4 SELC 3.0 0.0 11.0 22.0 63.5 99.5
G-SELC 0.0 0.0 1.5 0.0 98.5 100.0
EI 0.0 0.0 0.5 0.5 28.6 29.5
300 6 SELC 1.4 1.0 14.3 18.1 63.3 98.1
G-SELC 0.0 0.0 3.8 5.7 90.5 100.0
EI 0.0 0.6 0.4 0.8 44.0 45.8
10 SELC 2.6 0.4 11.8 20.6 63.8 99.2
G-SELC 0.6 0.0 4.2 9.0 86.2 100.0
size) represents the performance of EI, the middle one corresponds to SELC
and the right most one represents G-SELC.
It should be noted that, for each run size, the performance of SELC re-
mains nearly constant (which indicates insignificant “learning”) as the batch
size increases. The performance of G-SELC, for finding the maximum, de-
creases with the increase in batch size, whereas the trend is reversed for EI.
Furthermore, the adapted EI is quite powerful in identifying the global max-
imum and not so good in finding other near-optima, which is not surprising.
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Table 5
Performance of the three different methods based on 100 simulations—percentage of
success in identifying maxima of the Pavini function evaluated on a grid of 105 points
Order of
forbidden 25.59 25.60 25.62
array Run size Method (3rd best) (2nd best) (Max) Total
3
EI 4 0 0 4
150 SELC 0 1 0 1
G-SELC 7 2 0 9
EI 19 3 1 23
200 SELC 1 0 0 1
G-SELC 20 9 0 29
4
EI 4 0 0 4
150 SELC 0 1 0 1
G-SELC 4 0 0 4
EI 20 4 0 24
200 SELC 2 0 1 3
G-SELC 24 6 0 30
5D example (five dimensional problem). Similar to the 4D example setup,
consider a pharmaceutical experiment where a core molecule has five loca-
tions A, B, C, D and E, and ten monomers can be added to each of the five
locations. That is, 1≤ x·j ≤ 10 for j = 1, . . . ,5, and the response of interest
y(xi) is the desired chemical property of a compound with monomers speci-
fied by xi = (xi1, xi2, xi3, xi4, xi5). Now suppose that the responses were gen-
erated using the Paviani function [Andersen, Nielsen and Kreiborg (1998)]
f(x) =
5∑
i=1
(ln2(xi) + ln
2(11− xi))−
(
5∏
i=1
xi
)0.2
.
The performance of the three approaches is assessed based on its ability
to achieve the top 3 maxima of f(x), given by 25.59, 25.60 and 25.62. The
implementation starts with first finding a random minimax design of size
10×d= 50 for the initial design. The rest of the compounds are constructed
in batches of 10 until the budget allows. For this example, we consider both
forbidden arrays of order 3 and 4. The success rate of the three approaches
(SELC, EI and G-SELC) is averaged over 100 simulations.
None of these methods perform well for run size 150. This is not surprising,
considering the fact that here we are evaluating only 0.15% of all eligible
candidates. It is also expected that SELC will not perform well here because
the evolutionary algorithms would require more runs to reap the benefits.
As the top three maxima have very similar values, the last column of Table
G-SELC 17
5 is more informative. We see that the proposed method outperforms SELC
and adapted EI.
This example illustrates the limitations of SELC on a bigger search space
(i.e., the ratio N/M defined in Section 4 is really small). SELC does not
perform well simply because it cannot evaluate enough candidates. Under
such circumstances, the power of G-SELC lies mostly in its “systematic part”
which borrows strength from EI.
6. 3D example (pharmaceutical chemistry example) revisited. In this
section we illustrate the performance of G-SELC for the pharmaceutical
chemistry example discussed in Section 2. The goal is to find a subset of the
compound library that contains good compounds and hopefully the com-
pound(s) with highest process value. Recall that the compound library con-
sists of a total of 40,970 (= 5×34×241) compounds. However, the response,
y, values are available for only 1800 of these compounds [see Mandal et al.
(2007) for details]. Under these circumstances, the implementation of any
methodology is restricted to the exploration of only this set of 1800 com-
pounds. Ideally, one should suggest a subset of good compounds using the
information on the entire compound library.
The procedure starts by first finding a 50-point random minimax design
(Table 6) for creating an initial set of compounds that provides an overall
idea of the underlying process. Once the data for an initial design is obtained,
the Gaussian process model described in Section 3.2 is used to get a surrogate
of the underlying process. If the factors (input variables) are qualitative with
k levels, we treat them as quantitative with values 1,2, . . . , k. Then, we use
G-SELC to choose 48 more compounds in 12 batches of size 4 each. The
mixing ratio α is computed by taking c = 3/4 in equation (7). These 48
compounds from the follow-up runs along with the 50 compounds from the
initial design constitute the required subset of the compound library.
Based on the prior knowledge of the scientists, compounds with monomer
structure shown in Table 7 are also known to be uninteresting, and are
therefore placed in the forbidden array.
The mutation probabilities are weighted according to the average sub-
structure performance of the initial design (see Table 8). Each substruc-
ture (monomer) at location A receives the same baseline weighted mutation
probability (0.25× 1
4
). For the substructures with positive average response,
additional weights are assigned. For example, the additional weight for sub-
structure 2 is (0.8 / (0.8 + 0.36) = 0.69). The monomers for locations B
and C are treated similarly.
Table 9 presents the 48 new compounds obtained using G-SELC with
the afore-described forbidden array and mutation scheme. The left panel in
Table 9 shows the 24 compounds obtained from the EI steps, and the right
panel presents the compounds suggested by the SELC steps.
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Table 6
Initial design: set of compounds selected to fit a surrogate of the underlying process
A B C y A B C y
2 20 35 4 3 2 25 5
2 15 39 2 3 18 22 −3
2 15 9 5 3 9 19 0
2 20 41 −1 3 12 1 −4
2 2 15 −3 3 21 25 1
2 20 1 0 3 23 19 −1
2 23 6 4 3 3 7 −2
2 23 12 2 3 3 35 0
2 3 20 −3 3 8 10 0
2 14 21 −2 3 13 11 0
3 16 27 −9 3 19 30 17
3 9 39 33 3 14 16 1
3 6 39 1 3 8 2 3
3 7 30 −5 3 12 31 0
3 23 31 0 3 21 38 10
3 8 6 1 3 21 17 −7
3 18 13 7 3 3 11 −8
3 8 28 −3 3 18 4 −7
3 2 39 −3 3 9 14 −1
3 10 25 −3 3 12 38 −2
3 8 34 4 3 3 2 −4
3 18 10 3 3 7 22 0
3 13 6 2 3 2 31 −6
3 6 15 −1 3 15 33 −3
3 5 26 −2 4 13 38 −10
Table 7
Forbidden array from prior knowledge, for the pharmaceutical example
A B C A B C
1 19 10 3 21 22
1 19 22 3 21 23
1 21 10 4 19 10
3 10 3 4 19 20
3 19 10 4 19 28
3 19 22 4 21 20
3 21 20 4 21 23
Note that among these 48 new compounds, 3 compounds are good, that is,
with response y greater than 10. The best compound with y = 48 (A= 4,B =
21,
C = 30) has also been identified in these iterations. Of course, if the search
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space was not limited to only 1800 compounds, more good compounds are
likely to be captured in the batches of compounds. To compare the perfor-
mance of the proposed approach with SELC and the adapted EI algorithm,
we repeated this procedure 100 times. That is, starting with the same initial
design of size 50, we added 48 compounds sequentially in batches of size 4
each proposed by the G-SELC algorithm. Then, the number of good com-
pounds in the follow-up trials are recorded. Similarly, the number of good
compounds were recorded when SELC and adapted EI were used instead of
G-SELC. Results are summarized in Table 10.
In terms of capturing the maxima, it is clear that all the three approaches
perform poorly for this data set. This is not very surprising as the search
space is limited to only 1800 compounds and we are exploring only 5.5%
of them. Note that the adapted EI algorithm performs better for this ap-
plication in identifying the global maximum. Since identifying “good” com-
pounds is relatively more important compared to finding the “single best”
compound in this application, the performance of these algorithms can be
assessed based on the number of “good” compounds identified. The last row
of Table 10 represents the total number of good compounds (compounds
with response y greater than 10) obtained in 100 simulations. It is clear
that G-SELC identifies almost twice as many good compounds compared to
the other two techniques.
7. Summary and concluding remarks. The identification of promising
compounds from a large compound library is often very expensive. The pro-
posed approach G-SELC does this job efficiently, and requires exploration
of much fewer compounds from the library compared to other competing
methods. Of course, the relative performance of G-SELC depends on the
complexity of the underlying process. If the response surface is very smooth,
any reasonable search algorithm should work satisfactorily. For an extremely
complicated surface, almost complete enumeration might be needed irre-
spective of the efficiency of the search methods. For response surfaces whose
ruggedness lies in between, G-SELC is expected to perform well.
Table 8
Weighted mutation probabilities for each substructure at Position A, for the
pharmaceutical example
Substructure Average response Weighted mutation probability
1 NA = 0.25× 1
4
+0× 3
4
2 0.80 = 0.25× 1
4
+0.69× 3
4
3 0.36 = 0.25× 1
4
+0.31× 3
4
4 −10.00 = 0.25× 1
4
+0× 3
4
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Table 9
Suggested new compounds for the pharmaceutical chemistry example
A B C y A B C y
1 19 29 −2 1 1 10 −3
1 21 30 4 1 1 35 6
2 9 39 0 1 1 39 4
2 20 30 5 1 7 2 −5
3 8 39 4 1 7 21 −9
3 9 38 −4 1 10 39 6
3 9 40 −2 1 18 8 −3
3 10 38 −8 1 19 4 6
3 10 39 24 1 19 6 4
3 10 40 3 1 19 8 5
3 18 30 −3 1 19 13 4
3 19 29 3 1 19 21 0
3 19 31 −1 1 19 30 9
3 19 39 0 1 19 39 22
3 20 30 −7 1 19 40 2
3 20 38 −4 2 2 25 −4
3 21 30 9 2 9 8 −2
4 9 39 1 2 9 39 0
4 10 39 0 2 15 10 −1
4 20 30 −18 2 23 39 −4
4 21 29 −7 3 8 1 1
4 21 30 48 3 10 6 5
4 21 31 1 3 18 14 1
4 23 30 −3 3 21 5 −4
The implementation of G-SELC starts with finding a set of compounds
using a good n0-point space-filling design (we used random minimax de-
signs), where n0 is a small fraction of the total budget (N ) on the number
Table 10
Simulation results for the pharmaceutical example: Success rates of different methods for
identifying good compounds
EI SELC G-SELC
Success rate for identifying good compounds
Third best 92 100 95
Second best 0 0 4
Best 8 0 1
Total number of good compounds in 100 simulation
166 154 314
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of compounds to be manufactured. The modeling (1)–(4) of the data, ob-
tained from this set of compounds, provides an overall idea of the underlying
chemical process of interest. This is followed by finding the rest of the com-
pounds in batches of b compounds. G-SELC suggests that a batch with an
adaptive mixture of compounds proposed by SELC and adapted-EI is likely
to contain more “good” compounds compared to either of the two techniques
on their own. In the motivating pharmaceutical example, we observed that
G-SELC identifies almost twice as many “good” compounds compared to
the other two techniques.
A few additional remarks are worth noting. First, the EI formulation
used here is geared toward finding the best, and not other near-optimal
solutions. Thus, if properly formulated, the EI-based approach is likely to
perform better than the one used here, and will boost the performance of
G-SELC. Since formulating a new EI technique was not the motive here, we
used an adapted version of the existing approach.
Second, the Gaussian process model used here does not assume any prior
information regarding the behavior of the molecules. Since no such infor-
mation were available to us for the pharmaceutical example discussed in
Section 2, we used a constant µ. If scientists have prior information on the
shape of the underlying process, one could use a deterministic function µ(x)
instead of a constant µ. Such models are also known as blind kriging [Joseph,
Hung and Sujiantao (2008)].
Although we have used the power exponential correlation function (Gaus-
sian correlation function) throughout the paper, we investigated the perfor-
mance of G-SELC for the product Mate´rn correlation function with different
values of the smoothness parameter ν = 2.5, 3.5 and 5.5. It turns out that,
for the motivating pharmaceutical example in Section 6 and the simulated
examples in Section 5, the two correlation structures lead to very similar re-
sults for all the three methodologies presented here. Further investigations
on the distribution of the standardized predictions errors show that the two
types of correlation functions result in very similar predictions for several
test functions (e.g., the Le´vy function, the Paviani function, d = 4,5) and
the motivating pharmaceutical example. That is, based on our investiga-
tion, it is prudent to suggest that one could use either of the two correlation
functions for such modeling.
Finally, one of the most crucial points in such pharmaceutical applications
is that one or more of the factors are often qualitative, whereas G-SELC
methodology has been developed for quantitative factors. If there is a quan-
titative representation of the factors and their levels, our method is useful
for qualitative factors as well. Moreover, as argued in Section 2, it is often
feasible to rank the monomers (or reagents) based on their intrinsic chemical
properties. Although different properties might give rise to different order-
ings of the monomers, according to our experience, it does not affect the
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performance of our algorithm significantly. As a guide to practitioners, we
recommend using the physicochemical property which is the most important
according to the scientists’ prior knowledge for assigning the levels of the
factors. We have also investigated the impact of relabeling of factor(s) on the
proposed approach. The purpose of this investigation is to study the perfor-
mance of the proposed approach if one (or more) of the factors is qualitative
whose levels cannot be ordered. It turns out that the performance of all
the three methods (EI, SELC and G-SELC) for the pharmaceutical example
discussed in Section 6 is consistent with the results presented in Table 10
(see the Appendix for details). Nonetheless, the proposed methodology can
be extended for the qualitative factors. If one or more input factors are qual-
itative and cannot be treated as quantitative, one can use the correlation
function proposed by Qian, Wu and Wu (2008) to model the correlation
structure in the Gaussian process model. This is a topic for future research.
APPENDIX: SIMULATION STUDY FOR THE EFFECT OF
RELABELING
Similar to Table 9, Table 11 presents the success rates of the three method-
ologies for the pharmaceutical example when one of the factors was relabeled.
The results are based on 100 simulations. Here, the relabeling “A→A+ k”
denotes that the new level of A is mod(A+ k− 1, 5)+1. That is, A→A+2
corresponds to the following relabeling (1,2,3,4,5) −→ (3,4,5,1,2). Simi-
larly, the levels of B and C are relabeled to mod(B + k − 1, 34) + 1 and
mod(C + k− 1, 241) + 1, respectively.
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Table 11
Simulation results for the pharmaceutical example: success rates of different methods for
identifying good compounds, under different relabelings of the factors
EI SELC G-SELC EI SELC G-SELC EI SELC G-SELC EI SELC G-SELC
A→A+ 1 A→A+ 2 A→A+3 A→A+ 4
Third best 95 100 95 93 100 97 87 100 96 91 100 96
Second best 0 0 3 0 0 1 0 0 3 0 0 3
Best 5 0 2 7 0 2 13 0 1 9 0 1
Total number of 180 171 300 133 163 270 183 173 281 166 168 295
good compounds
in 100 simulations
B→B + 1 B→B +5 B→B +10 B→B + 20
Third best 89 100 100 94 99 98 90 100 95 87 100 90
Second best 0 0 0 0 1 2 1 0 4 0 0 10
Best 11 0 0 6 0 0 9 0 1 13 0 0
Total number of 144 189 264 175 180 260 164 189 275 167 191 305
good compounds
in 100 simulations
C→C + 1 C→C +10 C→C + 20 C→C + 30
Third best 86 100 98 83 100 97 86 99 97 86 100 96
Second best 0 0 2 0 0 2 0 1 3 0 0 4
Best 14 0 0 17 0 1 14 0 0 14 0 0
Total number of 173 174 277 171 196 288 166 166 314 176 191 296
good compounds
in 100 simulations
